Press releases
- Oxford BioDynamics signs supply and resale agreement with Agilent Technologies, and launches EpiSwitch® Explorer Array Kit for R&D use
- Agilent Awards Octagon Therapeutics with a Golden Ticket at LabCentral
- Agilent Announces Cash Dividend of 19.4 Cents per Share
- Agilent Announces the 8697 Headspace Sampler with Integrated Intelligence
- Dr. Katharine Knobil Named Agilent’s First Chief Medical Officer
- Agilent Completes CE-IVD Registration of qRT-PCR In Vitro Diagnostic Kit for SARS-CoV-2 RNA Detection
- Agilent Technologies Announces Pricing of $850 Million of Senior Notes
- Agilent Technologies Announces Proposed Offering of Senior Notes
- Agilent to Acquire Resolution Bioscience, Strengthening Leadership Position in Cancer Diagnostics
- Agilent Announces Darlene Solomon Award Presented to University of Geneva Scientist Noemi Jiménez-Rojo
More ▼
Key statistics
As of last trade Agilent Technologies Inc (AG8:FRA) traded at 110.00, -0.86% below its 52-week high of 110.95, set on Apr 07, 2021.
52-week range
Markit short selling activity
Open | 110.40 |
---|---|
High | 110.40 |
Low | 110.00 |
Bid | 109.80 |
Offer | 110.30 |
Previous close | 109.75 |
Average volume | 372.67 |
---|---|
Shares outstanding | 304.70m |
Free float | 304.48m |
P/E (TTM) | 50.63 |
Market cap | 40.19bn USD |
EPS (TTM) | 2.61 USD |
Annual div (ADY) | 0.6589 EUR |
---|---|
Annual div yield (ADY) | 0.60% |
Div ex-date | Apr 01 2021 |
Div pay-date | Apr 28 2021 |
Data delayed at least 15 minutes, as of Apr 12 2021 14:10 BST.
More ▼